Organization
Alexandra General Hospital
3 abstracts
Abstract
Belzutifan in patients with advanced clear cell renal cellcarcinoma (ccRCC): Subgroup analysis of the phase 2 LITESPARK-013 study.Org: University of Miami Hospital and Clinics, Cancer Research Services, New York Oncology Hematology, Moscow City Clinical Oncology Hospital No. 1, Alexandra General Hospital,
Abstract
Immunohistochemical expression of ER and p53 as predictive biomarkers of immunotherapy in endometrial cancer.Org: Alexandra Hospital - University of Athens, Medical School, School of Medicine, Zhejiang University, Hangzhou, China, National & Kapodistrian University of Athens, First dpt of Ob/Gyn, Oncology Unit S. Chiara Hospital, Trento, Italy,
Abstract
Prognostic and predictive significance of CA-125 elimination rate constant K (KELIM) in ovarian cancer patients treated with neoadjuvant chemotherapy in a real-world setting.Org: Haematology- Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital - University of Athens, Medical School, National and Kapodistrian University of Athens, School of Medicine, Zhejiang University, Hangzhou, China,